Broccoli seed extract, SULFODYNE, exhibits an antiviral effect in new preclinical study

The nutraceutical exhibited potent antiviral effects in both in vivo and in vitro studies, suggesting the potential of the plant-based active ingredient sulforaphane in protecting immune health

You need to be a subscriber to read this article.
Click here to find out more.

Ingood by Olga's broccoli seed extract, SULFODYNE, has been proven to act as a COVID-19 antiviral in two novel preclinical studies.1,2

SULFODYNE is a broccoli seed extract standardised and stabilised to 5% active and natural sulforaphane.

The trial, which explored the benefits of the nutraceutical both in vivo and in vitro, found that SULFODYNE can reduce the likelihood of COVID-19 infection via a range of mechanisms.

These results highlight the potential of the functional ingredient in supporting immune health and preventing seasonal viral infections.


Not yet a Subscriber?

This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Nutraceutical Business Review.

Subscribe now Already a subscriber? Sign in here.

You may also like